Investment Analysis - Stock Traders Daily
| CLPT Stock | USD 15.89 0.35 2.25% |
Slightly above 55% of Clearpoint Neuro's private investors are presently thinking to get in. The analysis of overall sentiment of trading Clearpoint Neuro stock suggests that some investors are interested at this time. Clearpoint Neuro's investing sentiment can be driven by a variety of factors including economic data, Clearpoint Neuro's earnings reports, geopolitical events, and overall market trends.
Clearpoint |
Investment Analysis Stock Traders Daily
Read at news.google.com
 |
Clearpoint Neuro Fundamental Analysis
We analyze Clearpoint Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearpoint Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearpoint Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Clearpoint Neuro is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Clearpoint Neuro Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearpoint Neuro stock to make a market-neutral strategy. Peer analysis of Clearpoint Neuro could also be used in its relative valuation, which is a method of valuing Clearpoint Neuro by comparing valuation metrics with similar companies.
Peers
Clearpoint Neuro Related Equities
| OM | Outset Medical | 19.66 | ||||
| APYX | Apyx Medical | 5.06 | ||||
| INSP | Inspire Medical | 5.02 | ||||
| INGN | Inogen | 4.68 | ||||
| RCEL | Avita Medical | 3.52 | ||||
| CTSO | Cytosorbents Crp | 2.17 | ||||
| KIDS | Orthopediatrics Corp | 2.10 | ||||
| ELMD | Electromed | 1.96 | ||||
| LIVN | LivaNova PLC | 1.33 | ||||
| TELA | Tela Bio | 1.04 | ||||
| LUNG | Pulmonx Corp | 0.46 | ||||
| TMCI | Treace Medical | 0.38 | ||||
| NPCE | Neuropace | 0.09 | ||||
| SRDX | SurModics | 0.40 | ||||
| SGHT | Sight Sciences | 2.51 | ||||
| NARI | Inari Medical | 3.92 |
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.